Clinical Trials Logo
  1. Home
  2. Hemangioma
  3. NCT02351245
  4. Details
NCT02351245 Clinical Trial

Clinical Characteristics of Lip Hemangiomas

Hemangioma Clinical Trial

Official title:
Clinical Characteristics and Complications of Infantile Hemangiomas Located in Lips

Clinical Trial Details — Status: Unknown status

Administrative data
NCT number NCT02351245
Other study ID # IH201412
Secondary ID
Status Unknown status
Phase N/A
First received January 19, 2015
Last updated January 26, 2015
Start date December 2014

Study information
Verified date January 2015
Source Zhujiang Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Lip hemangiomas are at higher risk than those located in other sites. However, studies about clinical characteristics of lip hemangiomas have not been enough. The investigators want to conduct a prospective study on the clinical features of lip hemangiomas.

Description:

Hemangiomas involving lip are of special concern, since they occur in a prominent location on the face and can distort lip anatomy and lead to disfunction. Infantile hemangiomas in lip had significantly higher incidence than the others. It is often difficult to decide which patient with an lip hemangioma is at higher risk.

The investigators are interested in conducting a study on the clinical features of lip hemangiomas. The investigators are collecting medical records and photos of lip hemangiomas, including demographic information, maternal process, birth, location, size and complication. Based on the data, sum up the main points of clinical characteristics and complication.

Recruitment information / eligibility
Status Unknown status
Enrollment 39
Est. completion date
Est. primary completion date February 2015
Accepts healthy volunteers No
Gender All
Age group N/A to 2 Years
Eligibility Inclusion Criteria:

- Only lip hemangiomas visiting between June 1, 2010 and October 1, 2014 were included in this study, which was defined as any infantile hemangioma covering any part of vermilion.

Exclusion Criteria:

- Perioral hemangiomas which did not involve vermilion were excluded.

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• observation

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
Zhujiang Hospital

Outcome
Type Measure Description Time frame Safety issue
Primary appearance time, location, size, complication of lip hemangiomas up to 2 months
Secondary demographic information up to 1 month
Secondary maternal specific events up to 1 month
See also
  Status Clinical Trial Phase
Completed NCT01685398 - Topical Timolol for Superficial Infantile Hemangioma Phase 3
Withdrawn NCT00974129 - A Study of CCCTC-binding Factor (CTCF) in Infantile Hemangiomas N/A
Completed NCT00374335 - Incidence of Hepatic Hemangiomatosis in Patients With Cutaneous Hemangiomas N/A
Recruiting NCT03331744 - Clinical Characteristics of Infantile Hemangioma
Completed NCT02342275 - Efficacy and Safety of Propranolol Versus Atenolol on the Proliferative Phase of Infantile Hemangioma Phase 3
Completed NCT00433940 - Immune Suppression Of Infants Treated With Steroids N/A
Completed NCT04065217 - The Effectiveness of Diode Laser 980-nm in Iraqi Face Hemangioma: a Randomized Within Patients Trial N/A
Terminated NCT01743885 - Efficacy and Safety of Propranolol Versus Acebutolol on the Proliferative Phase of Infantile Hemangioma Phase 3
Terminated NCT00555464 - Clinical Trial of Vincristine vs. Prednisolone for Treatment of Complicated Hemangiomas Phase 2
Completed NCT00394888 - Hemangioma Associated With High Rates of Morbidity N/A
Completed NCT05327309 - Role of Propranolol as Compared to Bleomycin in Management of Hemangioma N/A
Completed NCT02145884 - Topical Timolol Gel for the Treatment of Infantile Hemangiomas Phase 2
Completed NCT04077515 - Safety and Efficacy of Low-dose Sirolimus to Kaposiform Hemangioendothelioma Phase 4
Completed NCT02731287 - Topical Timolol for Infantile Hemangioma in Early Proliferative Phase Phase 2
Recruiting NCT01147601 - Topical Timolol 0.5% Solution for Proliferating Infantile Hemangiomas Phase 0
Completed NCT01908972 - The Safety and Efficiency of Propranolol as an Initial Treatment for Pediatric Hemangioma Phase 4
Completed NCT00540566 - Optical Biopsy of Human Skin in Conjunction With Laser Treatment
Completed NCT00001417 - Direct Injection of Alcohol for the Treatment of Spinal Tumors N/A
Completed NCT00004436 - Randomized Study of Hormonal Regulation of Infantile Hemangioma N/A
Recruiting NCT02496013 - Clinical Translation of a Novel Albumin-Binding PET Radiotracer 68Ga-NEB Phase 1